EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

JPH3 Facilitates Cisplatin Resistance in Anaplastic Thyroid Cancer via Activation of the JAK – STAT Signaling Pathway

Xiuyan Wang, Sha Luan, Lei Sun, Lixin Lian, Ming Qi iD

Cancer Medicine · 2026-03 · 15 (3)

DOI: 10.1002/cam4.71750 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer Medicine, online erschienen am 20.03.2026. Verfasst von Xiuyan Wang und 4 weiteren Autor:innen. Beteiligte Einrichtung: The Fourth Department of General Surgery, The First Hospital of Harbin, Harbin, Heilongjiang, China. Hauptthemen laut MEDLINE: Thyroid Carcinoma, Anaplastic, Cisplatin, Drug Resistance, Neoplasm, Janus Kinases. Die Arbeit nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Junctophilin 3 (JPH3) acts as a tumor suppressor in several cancers; however, the role of JPH3 in anaplastic thyroid cancer (ATC) is still unknown.

Methods

Via bioinformatics prediction and verified through Western blot experiments, the expression level of JPH3 in ATC was ascertained. Subsequently, the role of JPH3 in ATC cells was validated via in vitro and in vivo experiments, and the molecular mechanism of JPH3 in ATC was further illuminated. Eventually, the mechanism of JPH3 on cisplatin (DDP)‐resistant ATC cells was probed. The results indicated that JPH3 was highly expressed in thyroid cancer (TC), and the survival period of patients with high expression was significantly curtailed.

Results

JPH3 was upregulated in TC tissues compared with the normal thyroid tissues. Our experiments disclosed that JPH3 acted as an oncogene in ATC cells, facilitating tumor development, and JPH3 can activate the JAK–STAT signaling pathway by upregulation of collagen type XXVI alpha 1 chain (COL26A1), and experiments attested that JPH3 promoted the proliferation, invasion, and migration of ATC cells by activating the JAK–STAT signaling pathway. Further research uncovered that JPH3 was also involved in the process of DDP resistance in ATC cells. By activating the JAK–STAT signaling pathway, JPH3 induced the malignant phenotype of DDP‐resistant ATC cells.

Conclusions

JPH3 functions as a potent oncogenic driver in ATC, promoting tumor proliferation, invasion, and migration through the activation of the JAK–STAT signaling pathway. This oncoprotein contributes to enhanced DDP resistance in ATC cells via JAK–STAT‐mediated mechanisms, offering novel insights into the molecular basis of chemoresistance in this highly aggressive malignancy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Thyroid Carcinoma, AnaplasticCisplatinDrug Resistance, NeoplasmJanus KinasesThyroid NeoplasmsSTAT Transcription FactorsMembrane ProteinsHumansAnimalsSignal TransductionCell Line, TumorCell ProliferationMiceGene Expression Regulation, NeoplasticCell MovementAntineoplastic AgentsXenograft Model Antitumor AssaysFemale

Stichwörter der Autor:innen

COL26A1DDP resistanceJAK–STAT signaling pathwayJPH3anaplastic thyroid cancerthyroid cancer

Substanzen

CisplatinJanus KinasesSTAT Transcription FactorsMembrane ProteinsAntineoplastic Agents

Autor:innen und Institutionen

  • The Fourth Department of General Surgery, The First Hospital of Harbin, Harbin, Heilongjiang, China.
  • Department of Nuclear Medicine, The Fourth Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, China.
  • Department of Critical Care Medicine, The First Hospital of Harbin, Harbin, Heilongjiang, China.

ORCID-Profile: Ming Qi

Zitieren

APA

Wang, X., Luan, S., Sun, L., Lian, L., & Qi, M. (2026). JPH3 Facilitates Cisplatin Resistance in Anaplastic Thyroid Cancer via Activation of the JAK – STAT Signaling Pathway. Cancer Medicine, 15(3). https://doi.org/10.1002/cam4.71750

Vancouver

Wang X, Luan S, Sun L, Lian L, Qi M. JPH3 Facilitates Cisplatin Resistance in Anaplastic Thyroid Cancer via Activation of the JAK – STAT Signaling Pathway. Cancer Medicine. 2026;15(3). doi:10.1002/cam4.71750

BibTeX
@article{Wang2026,
  author = {Wang, Xiuyan and Luan, Sha and Sun, Lei and Lian, Lixin and Qi, Ming},
  title = {JPH3 Facilitates Cisplatin Resistance in Anaplastic Thyroid Cancer via Activation of the JAK – STAT Signaling Pathway},
  journal = {Cancer Medicine},
  year = {2026},
  volume = {15},
  number = {3},
  doi = {10.1002/cam4.71750}
}
Kostenlos starten →